These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8942399)

  • 21. Effects of chronic portal hypertension on agonist-induced actin polymerization in small mesenteric arteries.
    Chen X; Pavlish K; Zhang HY; Benoit JN
    Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1915-21. PubMed ID: 16339838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
    Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
    Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fructus aurantii reduced portal pressure in portal hypertensive rats.
    Huang YT; Wang GF; Chen CF; Chen CC; Hong CY; Yang MC
    Life Sci; 1995; 57(22):2011-20. PubMed ID: 7475952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic effects of eight-day octreotide and propranolol administration in portal hypertensive rats.
    Huang YT; Cheng YR; Lin HC; Hou MC; Lee SD; Hong CY
    Dig Dis Sci; 1998 Feb; 43(2):358-64. PubMed ID: 9512131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenteric vascular bed responsiveness in bile duct-ligated rats: roles of opioid and nitric oxide systems.
    Namiranian K; Samini M; Mehr SE; Gaskari SA; Rastegar H; Homayoun H; Dehpour AR
    Eur J Pharmacol; 2001 Jul; 423(2-3):185-93. PubMed ID: 11448484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats.
    Moreau R; Cailmail S; Valla D; Lebrec D
    Aliment Pharmacol Ther; 1997 Oct; 11(5):993-7. PubMed ID: 9354212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of somatostatin and octreotide on portal-systemic collaterals in portal hypertensive rats.
    Huang HC; Lee FY; Chan CC; Chang FY; Wang SS; Lin HC; Hou MC; Chen CT; Tai CC; Lai IN; Lee SD
    J Hepatol; 2002 Feb; 36(2):163-8. PubMed ID: 11830327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular actions of octreotide in the portal hypertensive rat.
    Aboud RW; Connolly C; McCormick PA; Docherty JR
    Br J Pharmacol; 1997 Oct; 122(4):698-702. PubMed ID: 9375966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DPP4 inhibitor reduces portal hypertension in cirrhotic rats by normalizing arterial hypocontractility.
    Wang X; Gu H; Li K; Lin J; Zhu Y; Deng W
    Life Sci; 2021 Nov; 284():119895. PubMed ID: 34450166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats.
    Moreno L; Martínez-Cuesta MA; Piqué JM; Bosch J; Esplugues JV
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):474-80. PubMed ID: 8897451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats.
    Tsai MH; Iwakiri Y; Cadelina G; Sessa WC; Groszmann RJ
    Gastroenterology; 2003 Nov; 125(5):1452-61. PubMed ID: 14598261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic administration of octreotide ameliorates portal hypertension and portal hypertensive gastropathy in rats with cirrhosis.
    Chan CC; Lee FY; Wang SS; Chang FY; Lin HC; Lin HJ; Chu CJ; Wu SL; Tai CC; Lee SD
    Clin Sci (Lond); 1998 Apr; 94(4):367-71. PubMed ID: 9640342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal vascular sensitivity to vasopressin in portal hypertensive rats.
    Mesh CL; Joh T; Korthuis RJ; Granger DN; Benoit JN
    Gastroenterology; 1991 Apr; 100(4):916-21. PubMed ID: 2001829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased vascular contractile and inositol phosphate responses in portal hypertensive rats.
    Huang YT; Yu PC; Lee MF; Lin HC; Hong CY; Yang MC
    Can J Physiol Pharmacol; 1995 Mar; 73(3):378-82. PubMed ID: 7648517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study on the vascular reactivity and alpha 1-adrenoceptors of portal hypertensive rats.
    Liao JF; Yu PC; Lin HC; Lee FY; Kuo JS; Yang MC
    Br J Pharmacol; 1994 Feb; 111(2):439-44. PubMed ID: 7911714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Octreotide ameliorates vasodilatation and Na+ retention in portal hypertensive rats.
    Albillos A; Colombato LA; Lee FY; Groszmann RJ
    Gastroenterology; 1993 Feb; 104(2):575-9. PubMed ID: 8425700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine study of portal hypertension associated endothelin-1 hypo-response.
    Theodorakis N; Maluccio M; Skill N
    World J Gastroenterol; 2015 Apr; 21(16):4817-28. PubMed ID: 25944995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular contractile response and signal transduction in endothelium-denuded aorta from cirrhotic rats.
    Lin HC; Yang YY; Huang YT; Lee TY; Hou MC; Lee FY; Lee SD
    World J Gastroenterol; 2005 Apr; 11(15):2306-12. PubMed ID: 15818743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased vascular responsiveness to alpha 2-adrenergic stimulation during NOS inhibition-induced hypertension.
    Kanagy NL
    Am J Physiol; 1997 Dec; 273(6):H2756-64. PubMed ID: 9435612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
    Hussain MB; Marshall I
    Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.